Your browser doesn't support javascript.
loading
Cribriform prostate cancer: Morphologic criteria enabling a diagnosis, based on survey of experts.
Iczkowski, Kenneth A; van Leenders, Geert J L H; Tarima, Sergey; Wu, Ruizhe; Van der Kwast, Theodorus; Berney, Daniel M; Evans, Andrew J; Wheeler, Thomas M; Ro, Jae Y; Samaratunga, Hemamali; Delahunt, Brett; Srigley, John; Varma, Murali; Tsuzuki, Toyonori; Egevad, Lars.
Afiliação
  • Iczkowski KA; Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, United States of America. Electronic address: kaiczkowski@mcw.edu.
  • van Leenders GJLH; Department of Pathology, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
  • Tarima S; Department of Biostatistics and Ethics, Medical College of Wisconsin, Milwaukee, WI, United States of America.
  • Wu R; Department of Biostatistics and Ethics, Medical College of Wisconsin, Milwaukee, WI, United States of America.
  • Van der Kwast T; Dept. of Pathology, Toronto General Hospital, Toronto, Canada.
  • Berney DM; Department of Pathology, Barts Health NHS TRUST, London, United Kingdom.
  • Evans AJ; Department of Pathology, Mackenzie Health, Richmond Hill, Ontario, Canada.
  • Wheeler TM; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, United States of America.
  • Ro JY; Department of Pathology & Genomic Medicine, Houston Methodist Hospital, Weill Medical College, Cornell University, Houston, TX, United States of America.
  • Samaratunga H; Department of Pathology, University of Queensland School of Medicine, Aquesta Uropathology, Queensland, Australia.
  • Delahunt B; Pathology and Molecular Medicine, University of Otago, Wellington, New Zealand.
  • Srigley J; Trillium Health Partners Mississauga, Ontario, Canada.
  • Varma M; Department of Cellular Pathology, University Hospital of Wales, Cardiff, Wales, United Kingdom.
  • Tsuzuki T; Department of Surgical Pathology, Aichi Medical University Hospital, Japan.
  • Egevad L; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Ann Diagn Pathol ; 52: 151733, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33780691
ABSTRACT
Among four sub-patterns of Gleason grade 4 prostate cancer, voluminous evidence supports that the cribriform pattern holds an unfavorable prognostic impact, as compared with poorly-formed, fused, or glomeruloid. The International Society of Urological Pathology (ISUP) recommends specifying whether invasive grade 4 cancer is cribriform. Recently, ISUP experts published a consensus definition of cribriform pattern highlighting criteria that distinguish it from mimickers. The current study aimed to analyze morphologic features separately to identify those that define the essence of the cribriform pattern. Thirty-two selected photomicrographs were classified by 12 urologic pathologists as definitely cribriform cancer, probably cribriform, unsure, probably not cribriform, or definitely not cribriform. Consensus was defined as 9/12 agree or disagree, with ≤1 strongly supporting the opposite choice. Final consensus was achieved in 21 of 32 cases. Generalized estimating equation (GEE) model with logit link was fitted to estimate effect of multiple morphologic predictors. Fisher exact test was used for categorical findings. Presence of intervening stroma precluded calling cribriform cancer (p = 0.006). Mucin presence detracted (p = 0.003) from willingness to call cribriform cancer (only 3 cases had mucin). Lumen number was associated with cribriform consensus (p = 0.0006), and all consensus cases had ≥9 lumens. Predominant papillary pattern or an irregular outer boundary detracted (p = NS). Invasive cribriform carcinoma should have absence of intervening stroma, and usually neither papillary pattern, irregular outer boundary, nor very few lumens. Setting the criteria for cribriform will help prevent over- or undercalling this important finding.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Adenocarcinoma / Gradação de Tumores / Invasividade Neoplásica Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Adenocarcinoma / Gradação de Tumores / Invasividade Neoplásica Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article